{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:56:17Z","timestamp":1791262577821,"version":"4.1.0"},"reference-count":19,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1397,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1002\/humu.21625","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T20:58:49Z","timestamp":1318366729000},"page":"95-99","source":"Crossref","is-referenced-by-count":69,"title":["Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients"],"prefix":"10.1155","volume":"33","author":[{"given":"Ella R.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha E.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina L.","family":"Ryland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Y.H.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"kConFab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Chenevix-Trench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison H.","family":"Trainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey J.","family":"Lindeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2011,11,4]]},"reference":[{"key":"10.1002\/humu.21625-BIB1|cit1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/bcr2619","article-title":"RAD51C germline mutations in breast and ovarian cancer patients","volume":"12","author":"Akbari","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1002\/humu.21625-BIB2|cit2","first-page":"211","article-title":"Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer","volume":"11","author":"Baxter","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/humu.21625-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1593\/neo.08718","article-title":"Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer","volume":"10","author":"Gorringe","year":"2008","journal-title":"Neoplasia"},{"key":"10.1002\/humu.21625-BIB4|cit4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/gcc.20694","article-title":"Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis","volume":"48","author":"Gorringe","year":"2009","journal-title":"Genes Chromosome Canc"},{"key":"10.1002\/humu.21625-BIB5|cit5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"key":"10.1002\/humu.21625-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1158\/0008-5472.CAN-06-3597","article-title":"Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays","volume":"67","author":"Jacobs","year":"2007","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21625-BIB7|cit7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","article-title":"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene","volume":"324","author":"Jones","year":"2009","journal-title":"Science"},{"key":"10.1002\/humu.21625-BIB8|cit8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"Meindl","year":"2010","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21625-BIB9|cit9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-102108-134222","article-title":"How the fanconi anemia pathway guards the genome","volume":"43","author":"Moldovan","year":"2009","journal-title":"Annu Rev Genet"},{"key":"10.1002\/humu.21625-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10549-011-1574-3","article-title":"RAD51C germline mutations in Chinese women with familial breast cancer","volume":"129","author":"Pang","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/humu.21625-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1093\/hmg\/ddr229","article-title":"RAD51C is a susceptibility gene for ovarian cancer","volume":"20","author":"Pelttari","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21625-BIB12|cit12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2006","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21625-BIB13|cit13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10549-011-1543-x","article-title":"A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families","volume":"129","author":"Romero","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/humu.21625-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2006","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21625-BIB15|cit15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/bcr2823","article-title":"Mutation screening of RAD51C in male breast cancer patients","volume":"13","author":"Silvestri","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1002\/humu.21625-BIB16|cit16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng.570","article-title":"Mutation of the RAD51C gene in a Fanconi anemia-like disorder","volume":"42","author":"Vaz","year":"2010","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21625-BIB17|cit17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10549-011-1443-0","article-title":"BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer","volume":"127","author":"Wong","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/humu.21625-BIB18|cit18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1002\/humu.21625-BIB19|cit19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10549-010-1095-5","article-title":"Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer","volume":"124","author":"Zheng","year":"2010","journal-title":"Breast Cancer Res Treat"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.21625","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/humu.21625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:52:48Z","timestamp":1672332768000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.21625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,4]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.21625","relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,4]]}}}